Literature DB >> 25947955

What's new in vasopressin?

D J P O'Callaghan1, Anthony C Gordon2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947955     DOI: 10.1007/s00134-015-3849-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  19 in total

Review 1.  Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis.

Authors:  Angelo Polito; Emilio Parisini; Zaccaria Ricci; Sergio Picardo; Djillali Annane
Journal:  Intensive Care Med       Date:  2011-11-30       Impact factor: 17.440

2.  Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.

Authors:  James A Russell; Chris Fjell; Joseph L Hsu; Terry Lee; John Boyd; Simone Thair; Joel Singer; Andrew J Patterson; Keith R Walley
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

3.  Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

Authors:  James A Russell; Keith R Walley; Anthony C Gordon; D James Cooper; Paul C Hébert; Joel Singer; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

4.  The effects of vasopressin on acute kidney injury in septic shock.

Authors:  Anthony C Gordon; James A Russell; Keith R Walley; Joel Singer; Dieter Ayers; Michelle M Storms; Cheryl L Holmes; Paul C Hébert; D James Cooper; Sangeeta Mehta; John T Granton; Deborah J Cook; Jeffrey J Presneill
Journal:  Intensive Care Med       Date:  2009-10-20       Impact factor: 17.440

5.  Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.

Authors:  Nattachai Anantasit; John H Boyd; Keith R Walley; James A Russell
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

6.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

7.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

8.  The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.

Authors:  Anthony C Gordon; Alexina J Mason; Gavin D Perkins; Martin Stotz; Marius Terblanche; Deborah Ashby; Stephen J Brett
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

Review 9.  Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.

Authors:  Ary Serpa Neto; Antônio P Nassar; Sérgio O Cardoso; José A Manetta; Victor G M Pereira; Daniel C Espósito; Maria C T Damasceno; James A Russell
Journal:  Crit Care       Date:  2012-08-14       Impact factor: 9.097

10.  Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine.

Authors:  Sangeeta Mehta; John Granton; Anthony C Gordon; Deborah J Cook; Stephen Lapinsky; Gary Newton; Kris Bandayrel; Anjuli Little; Chuin Siau; Dieter Ayers; Joel Singer; Terry C K Lee; Keith R Walley; Michelle Storms; D James Cooper; Cheryl L Holmes; Paul Hebert; Jeffrey Presneill; James A Russell
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

View more
  2 in total

1.  Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.

Authors:  Myura Nagendran; James A Russell; Keith R Walley; Stephen J Brett; Gavin D Perkins; Ludhmila Hajjar; Alexina J Mason; Deborah Ashby; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2019-05-06       Impact factor: 17.440

Review 2.  New Agents in Development for Sepsis: Any Reason for Hope?

Authors:  Philippe Vignon; Pierre-François Laterre; Thomas Daix; Bruno François
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.